Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2026-01-24 @ 7:40 AM
Study NCT ID:
NCT04698850
Status:
WITHDRAWN
Last Update Posted:
2022-08-10
First Post:
2021-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation
Sponsor:
Faculty Hospital Kralovske Vinohrady
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Wet Macular Degeneration | View |